Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.38
+1.14 (7.48%)
Apr 29, 2026, 4:08 PM HKT

HKG:2591 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
--174.69-733.38
Depreciation & Amortization
-16.7619.54
Other Amortization
-0.170.1
Loss (Gain) From Sale of Assets
-0.3-
Loss (Gain) From Sale of Investments
--0.19-1.13
Stock-Based Compensation
-16.04538.9
Other Operating Activities
--12.58-8.43
Change in Inventory
--25.590.23
Change in Accounts Payable
-2.7115.64
Change in Other Net Operating Assets
-14.463.92
Operating Cash Flow
--162.62-164.6
Capital Expenditures
--3.95-12.05
Sale (Purchase) of Intangibles
--0.38-0.15
Investment in Securities
-280.28-145.02
Investing Cash Flow
-275.95-157.21
Short-Term Debt Issued
-9.91
Total Debt Issued
-9.91
Short-Term Debt Repaid
--1-1
Long-Term Debt Repaid
--0.81-4.45
Total Debt Repaid
--1.81-5.45
Net Debt Issued (Repaid)
-8.1-4.45
Issuance of Common Stock
-250367.81
Other Financing Activities
--3.26-11.66
Financing Cash Flow
-254.84351.71
Foreign Exchange Rate Adjustments
-0.70.71
Net Cash Flow
-368.8730.61
Free Cash Flow
--166.57-176.64
Free Cash Flow Per Share
--0.40-0.46
Cash Interest Paid
-0.872.32
Levered Free Cash Flow
--95.73-
Unlevered Free Cash Flow
--95.18-
Change in Working Capital
--8.4119.79
Source: S&P Capital IQ. Standard template. Financial Sources.